Cargando…

A Novel Vitamin D Receptor Agonist, VS-105, Improves Bone Mineral Density without Affecting Serum Calcium in a Postmenopausal Osteoporosis Rat Model

BACKGROUND AND OBJECTIVES: VS-105, a novel vitamin D receptor agonist with significantly less hypercalcemic side effects than calcitriol, is a useful tool to investigate whether or not a vitamin D receptor agonist at non-hypercalcemic doses could improve bone mineral density (BMD). METHODS: VS-105 a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu-Wong, J. Ruth, Wessale, Jerry L., Chen, Yung-Wu, Chen, Theresa, Oubaidin, Maysaa, Atsawasuwan, Phimon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478347/ https://www.ncbi.nlm.nih.gov/pubmed/34589670 http://dx.doi.org/10.14218/jerp.2020.00020

Ejemplares similares

The use of teleorthodontics during the COVID-19 pandemic and beyond – perspectives of patients and providers
por: Homsi, Karen, et al.
Publicado: (2023)

VS-501: a novel, nonabsorbed, calcium- and aluminum-free, highly effective phosphate binder derived from natural plant polymer
por: Wu-Wong, J Ruth, et al.
Publicado: (2014)

Effects of vitamin D deficiency and daily calcium intake on bone mineral density and osteoporosis in Korean postmenopausal woman
por: Chon, Seung Joo, et al.
Publicado: (2017)

Extracorporeal shockwave treatment impedes tooth movement in rats
por: Atsawasuwan, Phimon, et al.
Publicado: (2018)

Efficacy and Safety of Denosumab in Osteoporosis or Low Bone Mineral Density Postmenopausal Women
por: Chen, Yi, et al.
Publicado: (2021)

Secretory microRNA-29 expression in gingival crevicular fluid during orthodontic tooth movement
por: Atsawasuwan, Phimon, et al.
Publicado: (2018)

Calcium and vitamin D supplementation with 3-year denosumab treatment is beneficial to enhance bone mineral density in postmenopausal patients with osteoporosis and rheumatoid arthritis
por: Suzuki, Takako, et al.
Publicado: (2018)

Vitamin D receptor gene polymorphisms, bone mineral density and fractures in postmenopausal women with osteoporosis
por: Horst-Sikorska, Wanda, et al.
Publicado: (2012)

Vitamin D Boosts Alendronate Tail Effect on Bone Mineral Density in Postmenopausal Women with Osteoporosis
por: Catalano, Antonino, et al.
Publicado: (2021)

Consideration of root position in virtual tooth setup for extraction treatment: A comparative study of simulated and actual treatment results
por: Park, Mirinae, et al.
Publicado: (2023)

Calcium and vitamin D intake by postmenopausal women with osteoporosis in Spain: an observational calcium and vitamin D intake (CaVIT) study
por: Fan, Tao, et al.
Publicado: (2013)

The Influence of Vitamin D Receptor Genetic Variants on Bone Mineral Density and Osteoporosis in Chinese Postmenopausal Women
por: He, Wei, et al.
Publicado: (2015)

The effects of minodronate and activated vitamin D on bone mineral density and muscle mass in postmenopausal women with osteoporosis
por: Fujimoto, Kazuki, et al.
Publicado: (2018)

Postmenopausal Osteoporosis
por: Kamel, Hosem K.
Publicado: (2006)

Ameloblastin Inhibits Cranial Suture Closure by Modulating Msx2 Expression and Proliferation
por: Atsawasuwan, Phimon, et al.
Publicado: (2013)

Effects of Long-Term Denosumab on Bone Histomorphometry and Mineralization in Women With Postmenopausal Osteoporosis
por: Dempster, David W, et al.
Publicado: (2018)

Tai Chi on bone mineral density of postmenopausal osteoporosis: A protocol for systematic review and meta-analysis
por: Wu, Hai-Yang, et al.
Publicado: (2020)

Regulatory SNP of RREB1 is Associated With Bone Mineral Density in Chinese Postmenopausal Osteoporosis Patients
por: Feng, Shuo, et al.
Publicado: (2021)

Salivary calcium as a diagnostic tool for screening of osteoporosis in postmenopausal women
por: Kumbhojkar, Shweta Vinayak, et al.
Publicado: (2019)

Vitamin K(2) Therapy for Postmenopausal Osteoporosis
por: Iwamoto, Jun
Publicado: (2014)

Effect of Abaloparatide vs Alendronate on Fracture Risk Reduction in Postmenopausal Women With Osteoporosis
por: Leder, Benjamin Z, et al.
Publicado: (2019)

Botanicals in Postmenopausal Osteoporosis
por: Słupski, Wojciech, et al.
Publicado: (2021)

COVID-19 infection rates and mitigation strategies in orthodontic practices
por: Durbin, Peter M, et al.
Publicado: (2023)

T-Cell Mediated Inflammation in Postmenopausal Osteoporosis
por: Wu, Di, et al.
Publicado: (2021)

Vitamin D Repletion in Korean Postmenopausal Women with Osteoporosis
por: Chung, Yoon-Sok, et al.
Publicado: (2016)

Romosozumab improves low bone mineral density in a postmenopausal woman undergoing chronic hemodialysis and treated with a calcium-sensing receptor agonist
por: Ogata, Masatomo, et al.
Publicado: (2022)

Gut microbiota and metabolite alterations associated with reduced bone mineral density or bone metabolic indexes in postmenopausal osteoporosis
por: He, Jianquan, et al.
Publicado: (2020)

Osteoporosis Risk Prediction for Bone Mineral Density Assessment of Postmenopausal Women Using Machine Learning
por: Yoo, Tae Keun, et al.
Publicado: (2013)

Effect of Denosumab on Bone Mineral Density and Markers of Bone Turnover among Postmenopausal Women with Osteoporosis
por: Sánchez, A., et al.
Publicado: (2016)

Abaloparatide effect on forearm bone mineral density and wrist fracture risk in postmenopausal women with osteoporosis
por: Watts, N.B., et al.
Publicado: (2019)

Does Bone Mineral Apparent Density Facilitate Accurate Identification of Osteoporosis in the Short Postmenopausal Women?
por: Subramaniam, Karthik, et al.
Publicado: (2020)

Effect of drugs on bone mineral density in postmenopausal osteoporosis: a Bayesian network meta-analysis
por: Migliorini, Filippo, et al.
Publicado: (2021)

Effect of Lifestyle Modification Intervention Programme on Bone Mineral Density among Postmenopausal Women with Osteoporosis
por: Anupama, D.S, et al.
Publicado: (2023)

Comparison between teriparatide and bisphosphonates for improving bone mineral density in postmenopausal osteoporosis patients: A meta-analysis
por: Fan, Guiyong, et al.
Publicado: (2020)

ERRATUM for “Effect of Abaloparatide vs Alendronate on Fracture Risk Reduction in Postmenopausal Women With Osteoporosis”
Publicado: (2020)

Low BMI, blood calcium and vitamin D, kyphosis time, and outdoor activity time are independent risk factors for osteoporosis in postmenopausal women
por: Tang, Guo, et al.
Publicado: (2023)

Pharmacokinetics of Teriparatide (rhPTH[1–34]) and Calcium Pharmacodynamics in Postmenopausal Women with Osteoporosis
por: Satterwhite, Julie, et al.
Publicado: (2010)

In silico analysis of the molecular mechanism of postmenopausal osteoporosis
por: LIU, YANQING, et al.
Publicado: (2015)

Biomarkers of postmenopausal osteoporosis and interventive mechanism of catgut embedding in acupoints
por: Chen, Guizhen, et al.
Publicado: (2020)

Bazedoxifene for the prevention of postmenopausal osteoporosis
por: Gennari, Luigi, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_g9l1fotusq3lolc57fm45s272m